Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Eli Lilly's GLP-1 Success, Capital Allocation, and Biotech Future
Understand how Eli Lilly capitalized on the GLP-1 breakthrough and discover the CEO’s strategy for pricing, R&D reinvestment, and future drug pipeline development.
Short Summary
- Eli Lilly's GLP-1 drug, Mounjaro, achieved record sales in Q2, highlighting a massive market shift toward metabolic health.
- Ricks emphasizes aggressive R&D reinvestment (targeting 25% of sales) over pure shareholder payouts to secure the next major breakthrough.
- The company is countering addiction and mental health crises by developing new GLP-1s specifically targeting brain activity.
- Lilly is countering supply chain risk and rising Chinese competition by committing to massive, localized US manufacturing expansion.
This interview provides deep insight from CEO Dave Ricks regarding the operational scaling, ethical pricing decisions, and the state of medical innovation financing post-GLP-1 boom. Readers gain context on how a pharma leader manages unprecedented profitability while balancing public health needs and future innovation.
Unlock all features
FREE: Get instant access to 10 AI summaries, chats, or transcripts per day.
Unlock all features
FREE: Get instant access to 10 AI summaries, chats, or transcripts per day.
Unlock all features
FREE: Get instant access to 10 AI summaries, chats, or transcripts per day.
Unlock all features
FREE: Get instant access to 10 AI summaries, chats, or transcripts per day.
Unlock all features
FREE: Get instant access to 10 AI summaries, chats, or transcripts per day.
Related videos
Elon’s Anthropic Deal, The Next AI Monopoly?, “FDA for AI” Panic, Trading the AI Boom
All-In Podcast
107.8k views
Debt Spiral or NEW Golden Age? Super Bowl Insider Trading, Booming Token Budgets, Ferrari's New EV
All-In Podcast
129.1k views
O'Shaquie Foster SNAPS On Shakur Stevenson, Podcast P & We Didn't Have Mental Health In The 80's!
Come And Talk 2 Me
134.7k views
Bernie Sanders: Stop All AI, China's EUV Breakthrough, Inflation Down, Golden Age in 2026?
All-In Podcast
107.7k views
Epstein Files Fallout, Nvidia Risks, Burry's Bad Bet, Google's Breakthrough, Tether's Boom
All-In Podcast
200.2k views
Heather Cox Richardson: Trump Is Mentally Crumbling—But Still Dangerous | The Bulwark Podcast
The Bulwark
848.9k views
Trump Brokers Gaza Peace Deal, National Guard in Chicago, OpenAI/AMD, AI Roundtripping, Gold Rally
All-In Podcast
353.3k views
YouTube CEO Neal Mohan on AI, Censorship & the Future of Creators
All-In Podcast
63.6k views
Jaylon Johnson NFL lockdown CB on Ben Johnson's new regime in Chicago, Caleb Williams & addiction.
The Pivot Podcast
113.8k views
Demi Lovato on Her ICONIC New Music Video, Past Eras & Mental Health Journey | Just Trish Ep. 210
JUST TRISH PODCAST
640.9k views
Top Comments (10)
Jason constantly oscillates between being the most cringe bestie and funniest bestie.
30 minutes is not enough for this interview
This guy is impressive
Thank you Dave Ricks. I only took Mounjaro for 4 months. Lost a total of over 60 lbs. and have kept it off without the drug.
Great explanation on the current state of Biotech venture. Investing in these companies post IPO has devolved into binary event gambling to anyone except the 1% who can rationalize the drug’s MOA.
Great interview
Great interview refreshingly honest and forthcoming. It's like if you had a conversation with this guy you could trust what he would tell you
I just wanna give a S/O to sacks for his insights and contributions to this panel 🙌🏽🙌🏽
Great interview held his ground while being ask ten different questions at once, really enjoyed.
chamath dry humpping his mic on the tie is gold. Why did nobody say or notice... Thank you all for all your hard work!
Unlock the Data Inside
Turn Videos into Knowledge
- Get FREE 10/day: transcripts, summaries, chats
- Chat with videos, export text & PDF
- $1 free API credit for RAG, chatbots & research
Free forever plan • All features unlocked
Top Comments (10)
Jason constantly oscillates between being the most cringe bestie and funniest bestie.
30 minutes is not enough for this interview
This guy is impressive
Thank you Dave Ricks. I only took Mounjaro for 4 months. Lost a total of over 60 lbs. and have kept it off without the drug.
Great explanation on the current state of Biotech venture. Investing in these companies post IPO has devolved into binary event gambling to anyone except the 1% who can rationalize the drug’s MOA.
Great interview
Great interview refreshingly honest and forthcoming. It's like if you had a conversation with this guy you could trust what he would tell you
I just wanna give a S/O to sacks for his insights and contributions to this panel 🙌🏽🙌🏽
Great interview held his ground while being ask ten different questions at once, really enjoyed.
chamath dry humpping his mic on the tie is gold. Why did nobody say or notice... Thank you all for all your hard work!